Abstract
A novel class of tetrahydro-pyrazinopyrimidine-2-carboxamides have been identified as HIV-1 integrase inhibitors. Optimization of the initial lead culminated in the discovery of a series of compounds with high potency on the enzyme and an antiviral cell-based activity equivalent to that showed by Raltegravir, the first in class HIV-1 integrase inhibitor.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Cell Line
-
Chemistry, Pharmaceutical / methods
-
Drug Design
-
HIV Integrase Inhibitors / chemical synthesis*
-
HIV Integrase Inhibitors / pharmacology
-
Humans
-
Inhibitory Concentration 50
-
Magnetic Resonance Spectroscopy / methods
-
Models, Chemical
-
Nitrogen / chemistry
-
Pyrazines / chemical synthesis*
-
Pyrazines / pharmacology
-
Pyrimidines / chemical synthesis*
-
Pyrimidines / pharmacology
-
Rats
-
Stereoisomerism
-
Structure-Activity Relationship
Substances
-
HIV Integrase Inhibitors
-
Pyrazines
-
Pyrimidines
-
Nitrogen